Rare driver alterations in nonsmall cell lung cancer: novel targeted drugs
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference50 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Prevalence and natural history of ALK positive nonsmall-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors;Chia;Clin Epidemiol,2014
3. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap);Dearden;Ann Oncol,2013
4. Co-occurring genomic alterations in nonsmall-cell lung cancer biology and therapy;Skoulidis;Nat Rev Cancer,2019
5. A narrative review of MET inhibitors in nonsmall cell lung cancer with MET exon 14 skipping mutations;Santarpia;Transl Lung Cancer Res,2021
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 1,2,3-Triazole Tethered Hybrid Capsaicinoids as Antiproliferative Agents Active against Lung Cancer Cells (A549);ACS Omega;2022-09-01
2. Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer;Współczesna Onkologia;2022
3. Editorial: Lung cancer: continuous progress in diagnosis and treatment;Current Opinion in Oncology;2021-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3